Biochemical modulation of cytarabine triphosphate by clofarabineCOOPER, Todd; AYRES, Mary; NOWAK, Billie et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 4, pp 361-368, issn 0344-5704, 8 p.Article

A sensitive new method for clinically monitoring cytarabine concentrations at the DNA level in leukemic cellsYAMAUCHI, Takahiro; UEDA, Takanori.Biochemical pharmacology. 2005, Vol 69, Num 12, pp 1795-1803, issn 0006-2952, 9 p.Article

Purification and characterization of an amidohydrolase for N⁴-long-chain fatty acyl derivatives of 1-β-D-arabinofuranosylcytosine from mouse liver microsomes = Purification et caractérisation d'une amidohydrolase par les dérivés N4 acyl de la 1-bêta-D-arabinofuranosylcytosine avec des acides gras à longue chaîne provenant des microsomes du foie de sourisHORI, K; TSURUO, T; TSUKAGOSHI, S et al.Cancer research (Baltimore). 1984, Vol 44, Num 3, pp 1187-1193, issn 0008-5472Article

COMPARATIVE REACTIVITY OF CYTIDINE AND ARABINOSYLCYTOSINE TO THEIR 6-METHYL DERIVATIVES IN THE PRESENCE OF CYTIDINE DEAMINASEDEYOUNG JL; NOTARI RE; FELLER DR et al.1974; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1974; VOL. 9; NO 1; PP. 163-172; BIBL. 9REF.Article

Liposomal cytarabine in cerebrospinal fluidBOYD, Kevin; JENNER, Matthew; TRELEAVEN, Jennie et al.British journal of haematology. 2009, Vol 145, Num 6, issn 0007-1048, p. 679Article

EFFECT OF CYTOSINE ARABINOSIDE AND TWO OF ITS ANALOGUES ON HERPES SIMPLEX VIRUS TYPE 1 IN CELL CULTURESMATSUMOTO S; SUGANUMA T; ISHIDA N et al.1974; TOHOKU J. EXPER. MED.; JAP.; DA. 1974; VOL. 114; NO 4; PP. 393-394; BIBL. 3 REF.Article

Cerebrospinal fluid and plasma pharmacokinetics of high doses of 1-β-D-arabinofuranosylcytosine in nonhuman primates = Pharmacocinétique de fortes doses de 1-bêta-D-arabinofuranosyl cytosine dans le liquide céphalo-rachidien et le plasma chez les primates non humainsLOPEZ, J. A; BEARDSLEY, G. P; KRIKORIAN, J. G et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5190-5193, issn 0008-5472Article

Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitisKLEITER, I; HANS, V. H; SCHUIERER, G et al.Journal of neurology, neurosurgery and psychiatry. 2004, Vol 75, Num 9, pp 1346-1348, issn 0022-3050, 3 p.Article

Cytarabine-associated lymphoid dyscrasia with atypical T CD30+ infiltrate in a patient suffering from acute nonlymphoblastic leukaemiaPENATE, Y; GUILLERMO, N; HERNANDEZ-MACHIN, B et al.British journal of dermatology (1951). 2009, Vol 160, Num 5, pp 1122-1123, issn 0007-0963, 2 p.Article

In vitro sensitivity of various human tumors to 1-beta-D-arabinofuranosylcytosine and N⁴-behenoyl-1-beta-D-arabinofuranosylcytosineMAEHARA, Y; KUSUMOTO, T; KUSUMOTO, H et al.Chemotherapy (Basel). 1989, Vol 35, Num 3, pp 181-186, issn 0009-3157Article

Cytokinetic study on the effects of N⁴-behenoyl-1-β-D-arabinofuranosylcytosine on murine leukemic cells L 1210: a comparison with the effects of 1-β-D-arabinofuranosylcytosineMARUO, N; HORIUCHI, H; NAKABO, T et al.Hematological oncology. 1985, Vol 3, Num 1, pp 39-48, issn 0278-0232Article

Low-dose ARA-C fails to enhance differentiation of leukaemic cellsPERRI, R. T; WEISDORF, D. J; OKEN, M. M et al.British journal of haematology. 1985, Vol 59, Num 4, pp 697-701, issn 0007-1048Article

Biophysical characterization of a liposomal formulation of cytarabine and daunorubicinDICKO, Awa; KWAK, Sungjong; FRAZIER, April A et al.International journal of pharmaceutics (Print). 2010, Vol 391, Num 1-2, pp 248-259, issn 0378-5173, 12 p.Article

The freeze-thawed and freeze-dried stability of cytarabine-encapsulated multivesicular liposomesCHENGJUN CHEN; DANDAN HAN; YU ZHANG et al.International journal of pharmaceutics (Print). 2010, Vol 387, Num 1-2, pp 147-153, issn 0378-5173, 7 p.Article

Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia : single activity and combination with other antileukemic drugsFIEGL, Michael; LINDNER, Lars H; JUERGENS, Matthias et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 2, pp 321-329, issn 0344-5704, 9 p.Article

Metabolism of the new liposomal anticancer drug N⁴-octadecyl-1-β-d-arabinofuranosylcytosine in miceKOLLER-LUCAE, S. K. M; SUTER, M. J.-F; RENTSCH, K. M et al.Drug metabolism and disposition. 1999, Vol 27, Num 3, pp 342-350, issn 0090-9556Article

ROLE OF DEPHOSPHORYLATION IN ACCUMULATION OF 1-BETA -D-ARABINOFURANOSYLCYTASINE 5'-TRIPHOSPHATE IN HUMAN LYMPHOBLASTIC CELL LINES WITH REFERENCE TO THEIR DRUG SENSITIVITYABE I; SAITO S; HORI K et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 7; PP. 2846-2851; BIBL. 46 REF.Article

Potentiation of 1-β-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60 = Potentialisation du métabolisme et de la cytotoxicité de la 1-bêta-D-arabinofuranosylcytosine par le 2,3-dihydro-1H-imidazolo (1,2-b) pyrazole dans les cellules de leucémie promyélocytaire humaine, HL-60GRANT, S; BHALLA, K; RAUSCHER, F. III et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5093-5100, issn 0008-5472Article

Clinical pharmacology of N⁴-palmitoyl-1-β-D-arabinofuranosylcytosine in patients with hematologic malignanciesUEDA, T; NAKAMURA, T; KAGAWA, D et al.Cancer chemotherapy and pharmacology. 1989, Vol 24, Num 6, pp 371-375, issn 0344-5704Article

Contrôle d'uniformité de teneur des préparations injectables de Cytarabine = Quality control of injectable preparations containing cytarabine : détermination of cytarabine concentrationsCOLLIN, Cedric; CAMUS, Maryse; ALBOUSSIERE, Medhi et al.Le Pharmacien hospitalier. 2008, Vol 43, Num 172, pp 29-34, issn 0768-9179, 6 p.Article

Cell differentiation effects of 2'-fluoro-1-β-D-arabinofuranosyl pyrimidines in HL-60 cellsXIANG-BIN KONG; ANDREEFF, M; FANUCCHI, M. P et al.Leukemia research. 1987, Vol 11, Num 11, pp 1031-1039, issn 0145-2126Article

2.133.763 (B) (7213244). - 14AVRIL 1972. PROCEDE DE PRODUCTION DE LA 2,2-ANHYDRO-(1-BETA -D-ARABINOFURANOSYL)CYTOSINEsdPatent

Modeling the pharmacodynamics of highly schedule-dependent agents : Exemplified by cytarabine-based regimens in acute myeloid leukemiaBRAESS, Jan; FIEGL, Michael; LORENZ, Isolde et al.Clinical cancer research. 2005, Vol 11, Num 20, pp 7415-7425, issn 1078-0432, 11 p.Article

High-Dose Cytarabine Induction Is Well Tolerated and Active in Patients With de Novo Acute Myeloid Leukemia Older Than 60 YearsARELLANO, Martha; WINTON, Elliott; LANGSTON, Amelia et al.Cancer. 2012, Vol 118, Num 2, pp 428-433, issn 0008-543X, 6 p.Article

Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayersGRAZIA SARPIETRO, Maria; OTTIMO, Sara; GIUFFRIDA, Maria Chiara et al.International journal of pharmaceutics (Print). 2011, Vol 406, Num 1-2, pp 69-77, issn 0378-5173, 9 p.Article